SCHEMBL12145396

SCHEMBL12145396

C=C(C)NCCOC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15834582 0.85
SCHEMBL23810488 0.81 ALDH1A1 (0.45)
SCHEMBL150973 0.77 TDP1 (0.45)
SCHEMBL209638 0.74
SCHEMBL764602 0.74
SCHEMBL12012311 0.74
SCHEMBL12530457 0.73 MAPK1 (0.30)
SCHEMBL19319078 0.73 ALDH1A1 (0.36)
SCHEMBL22149963 0.73 MEN1 (0.50)
SCHEMBL23841863 0.73 EPHX2 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912708-B2 Macrocyclic heterocycles and uses thereof KUMQUAT BIOSCIENCES INC. (US) 2024-02-27 US disclosed
US-20230339952-A1 MACROCYCLIC HETEROCYCLES AND USES THEREOF KUMQUAT BIOSCIENCES INC. 2023-10-26 US disclosed
WO-2014100719-A2 PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-06-26 WO disclosed
US-20130172349-A1 INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE NOVARTIS AG (CH) 2013-07-04 US disclosed
US-8404684-B2 Inhibitors of phosphatidylinositol 3-kinase NOVARTIS AG (CH) 2013-03-26 US disclosed
US-20110288337-A1 PROCESS FOR PREPARING 2-(2-TERT-BUTYLAMINOETHOXY)ETHANOL (TERT-BUTYLAMINODIGLYCOL, TBADG) BASF SE (DE) 2011-11-24 US disclosed
US-20080139493-A1 Bi- or Tetra-Guanidino-Biphenyl Compounds as Small Molecule Carriers UCL BUSINESS PLC (GB) 2008-06-12 US disclosed